We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ED-Home Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03864341
Recruitment Status : Completed
First Posted : March 6, 2019
Results First Posted : August 19, 2022
Last Update Posted : August 19, 2022
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
This is a single-arm pilot study to test the feasibility of homelessness prevention and substance use interventions to be delivered to at-risk patients in the Bellevue Hospital emergency department (ED). ED patients (n=40) found eligible for the study will complete a baseline assessment and receive referrals to appropriate services, with a final six-month follow-up assessment.

Condition or disease Intervention/treatment Phase
Housing Problems Drug Use Alcohol; Use, Problem Behavioral: Referral to homelessness prevention services Behavioral: Substance use services Behavioral: Follow-up Not Applicable

Detailed Description:
ED patients found eligible for the study will complete a baseline survey and receive one-time, in person services at the time of the baseline/enrollment ED visit including referrals to homelessness prevention and substance use services, with a final six-month follow-up survey. Interim contacts at 7-10 days, 3 months, and 5 months will be used to assure intervention components were received and to confirm participant contact information.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: ED-Home: A Pilot Feasibility Study of a Homelessness Prevention Intervention for Substance Using Emergency Department Patients
Actual Study Start Date : May 8, 2019
Actual Primary Completion Date : March 23, 2020
Actual Study Completion Date : March 23, 2020

Arm Intervention/treatment
Experimental: Homelessness Prevention Services Behavioral: Referral to homelessness prevention services
Referral to Homebase homelessness prevention services offered by community-based organizations in NYC

Behavioral: Substance use services
Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital

Behavioral: Follow-up
Follow-up to assist participants in receiving homelessness prevention services




Primary Outcome Measures :
  1. Percentage of Potential Participants Approached Who Were Eligible for the Study [ Time Frame: Month 6 ]
  2. Percentage of Eligible Participants Who Agreed to Participate in the Study [ Time Frame: Month 6 ]
  3. Number of Participants Who Received Referrals for Homelessness Prevention and/or Substance Use Services [ Time Frame: Month 6 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Be a patient in the Bellevue Hospital Center ED.
  • Be ≥18 years old.
  • Screen positive for homelessness risk using a homelessness risk screening tool (HRST).
  • Screen positive for unhealthy alcohol or drug use.
  • Able to provide consent.

Exclusion Criteria:

  • Medically (e.g., critically ill) or psychiatrically unstable.
  • Unable to provide informed consent for other reason (e.g., cognitive deficit, profound intoxication).
  • Incarcerated or in police custody.
  • Unable to understand and speak English.
  • Lives outside NYC and/or cannot give a NYC ZIP code.
  • Already homeless (residing in a shelter or on the streets).
  • Does not have a telephone where can be reached for follow-up.
  • Has already received specialized peer navigator/addiction social worker services during current ED visit.
  • Has already participated in the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03864341


Locations
Layout table for location information
United States, New York
New York University School of Medicine
New York, New York, United States, 10016
Sponsors and Collaborators
NYU Langone Health
National Institute on Drug Abuse (NIDA)
Investigators
Layout table for investigator information
Principal Investigator: Kelly Doran, MD, MHS New York Langone Medical Center
  Study Documents (Full-Text)

Documents provided by NYU Langone Health:
Informed Consent Form  [PDF] March 12, 2019

Layout table for additonal information
Responsible Party: NYU Langone Health
ClinicalTrials.gov Identifier: NCT03864341    
Other Study ID Numbers: 18-02040
K23DA039179 ( U.S. NIH Grant/Contract )
First Posted: March 6, 2019    Key Record Dates
Results First Posted: August 19, 2022
Last Update Posted: August 19, 2022
Last Verified: July 2022

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Alcohol Drinking
Drinking Behavior